Meningococcal carriage 7 years after introduction of a serogroup A meningococcal conjugate vaccine in Burkina Faso: results from four cross-sectional carriage surveys

BACKGROUND: In the first 2 years after a nationwide mass vaccination campaign of 1–29-year-olds with a meningococcal serogroup A conjugate vaccine (MenAfriVac) in Burkina Faso, carriage and disease due to serogroup A Neisseria meningitidis were nearly eliminated. We aimed to assess the long-term eff...

Descripción completa

Detalles Bibliográficos
Autores principales: Mbaeyi, Sarah, Sampo, Emmanuel, Dinanibè, Kambiré, Yaméogo, Issaka, Congo-Ouédraogo, Malika, Tamboura, Mamadou, Sawadogo, Guetawendé, Ouattara, Kalifa, Sanou, Mahamadou, Kiemtoré, Tanga, Dioma, Gerard, Sanon, Barnabé, Somlaré, Hermann, Kyetega, Augustin, Ba, Absatou Ky, Aké, Flavien, Tarbangdo, Félix, Aboua, Frederic Acho, Donnou, Yvette, Kamaté, Idrissa, Patel, Jaymin C, Schmink, Susanna, Spiller, Michael W, Topaz, Nadav, Novak, Ryan, Wang, Xin, Bicaba, Brice, Sangaré, Lassana, Ouédraogo-Traoré, Rasmata, Kristiansen, Paul A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science ;, The Lancet Pub. Group 2020
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689286/
https://www.ncbi.nlm.nih.gov/pubmed/32653071
http://dx.doi.org/10.1016/S1473-3099(20)30239-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7689286/
https://www.ncbi.nlm.nih.gov/pubmed/32653071
http://dx.doi.org/10.1016/S1473-3099(20)30239-5

Ejemplares similares